[Journal logo]

Volume 64 
Part 3 
Page o608  
March 2008  

Received 8 February 2008
Accepted 14 February 2008
Online 20 February 2008

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.005 Å
R = 0.048
wR = 0.101
Data-to-parameter ratio = 6.7
Details
Open access

2-(2-Benzyloxyphenyl)-1H-benzimidazole

aFacultad de Farmacia, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001 Col., Chamilpa, CP 62100, Cuernavaca Mor., Mexico, and bCentro de Investigaciones Químicas, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001 Col., Chamilpa, CP 62100, Cuernavaca Mor., Mexico
Correspondence e-mail: tlahuext@ciq.uaem.mx

The asymmetric unit of the title compound, C20H16N2O, contains two molecules. The dihedral angles between the benzimidazole ring systems and the attached benzene rings are 10.6 (5) and 13.7 (5)°. The conformers are linked by bifurcated three-centre hydrogen bonds, forming chains along the diagonal of the ab plane. The packing is further stabilized by [pi]-[pi] and C-H...[pi] interactions.

Related literature

For general background, see: Desiraju & Steiner (1999[Desiraju, G. & Steiner, T. (1999). The Weak Hydrogen Bond in Structural Chemistry and Biology, pp. 5-6. New York: Oxford University Press.]); Lehn (1990[Lehn, J.-M. (1990). Angew. Chem. Int. Ed. Engl. 29, 1304-1319.]); Saenger (1984[Saenger, W. (1984). Principles of Nucleic Acid Structure, pp. 132-140. New York: Springer-Verlag.]); Wakelin (1986[Wakelin, L. P. G. (1986). Med. Res. Rev. 6, 275-340.]). For related structures, see: Estrada-Soto et al. (2006[Estrada-Soto, S., Villalobos-Molina, R., Aguirre-Crespo, F., Vergara-Galicia, J., Moreno-Diaz, H., Torres-Piedra, M. & Navarrete-Vázquez, G. (2006). Life Sci. 79, 430-435.]); Moreno-Diaz et al. (2006[Moreno-Diaz, H., Navarrete-Vázquez, G., Estrada-Soto, S. & Tlahuext, H. (2006). Acta Cryst. E62, o2601-o2602.]); Navarrete-Vázquez et al. (2006[Navarrete-Vázquez, G., Moreno-Diaz, H., Aguirre-Crespo, F., León-Rivera, I., Villalobos-Molina, R., Muñoz-Muñiz, O. & Estrada-Soto, S. (2006). Bioorg. Med. Chem. Lett. 16, 4169-4173.]).

[Scheme 1]

Experimental

Crystal data
  • C20H16N2O

  • Mr = 300.35

  • Monoclinic, C c

  • a = 11.526 (2) Å

  • b = 17.210 (3) Å

  • c = 15.866 (3) Å

  • [beta] = 90.52 (3)°

  • V = 3147.0 (11) Å3

  • Z = 8

  • Mo K[alpha] radiation

  • [mu] = 0.08 mm-1

  • T = 293 (2) K

  • 0.31 × 0.21 × 0.17 mm

Data collection
  • Bruker SMART CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Sheldrick, 2003[Sheldrick, G. M. (2003). SADABS. Version 2.10. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.976, Tmax = 0.987

  • 7808 measured reflections

  • 2830 independent reflections

  • 2691 reflections with I > 2[sigma](I)

  • Rint = 0.038

Refinement
  • R[F2 > 2[sigma](F2)] = 0.048

  • wR(F2) = 0.100

  • S = 1.17

  • 2830 reflections

  • 423 parameters

  • 2 restraints

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.20 e Å-3

  • [Delta][rho]min = -0.20 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

Cg1 is the centroid of the C27/N4/C26/C21/N3 imidazole ring, and Cg2, Cg3 and Cg4 are the centroids of the C28-C33, C15-C20 and C35-C40 benzene rings, respectively.

D-H...A D-H H...A D...A D-H...A
N1-H1...O1 0.89 (4) 2.20 (3) 2.667 (4) 112 (3)
N1-H1...N4i 0.89 (4) 2.18 (3) 3.008 (4) 154 (3)
N3-H3A...O2 0.83 (4) 2.20 (5) 2.670 (4) 117 (4)
N3-H3A...N2ii 0.83 (4) 2.18 (5) 2.918 (4) 148 (4)
C14-H14A...Cg1i 0.97 2.88 3.736 (4) 148
C14-H14B...Cg4iii 0.97 2.92 3.721 (4) 141
Cg3...Cg2i     3.859 (2)  
Symmetry codes: (i) [x-1, -y+1, z-{\script{1\over 2}}]; (ii) [x+{\script{1\over 2}}, -y+{\script{1\over 2}}, z+{\script{1\over 2}}]; (iii) x-1, y, z-1.

Data collection: SMART (Bruker, 2000[Bruker (2000). SMART. Version 5.618. Bruker AXS Inc, Madison, Wisconsin, USA.]); cell refinement: SAINT-Plus NT (Bruker, 2001[Bruker (2001). SAINT-Plus NT. Version 6.04. Bruker AXS Inc, Madison, Wisconsin, USA.]); data reduction: SAINT-Plus NT; program(s) used to solve structure: SHELXTL-NT (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXTL-NT; molecular graphics: SHELXTL-NT; software used to prepare material for publication: PLATON (Spek, 2003[Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SJ2464 ).


Acknowledgements

This work was supported by the Consejo Nacional de Ciencia y Tecnología (CONACyT) under grant Nos. 3562P-E and PROMEP-SEP UAEMOR-PTC-131 (GNV).

References

Bruker (2000). SMART. Version 5.618. Bruker AXS Inc, Madison, Wisconsin, USA.
Bruker (2001). SAINT-Plus NT. Version 6.04. Bruker AXS Inc, Madison, Wisconsin, USA.
Desiraju, G. & Steiner, T. (1999). The Weak Hydrogen Bond in Structural Chemistry and Biology, pp. 5-6. New York: Oxford University Press.
Estrada-Soto, S., Villalobos-Molina, R., Aguirre-Crespo, F., Vergara-Galicia, J., Moreno-Diaz, H., Torres-Piedra, M. & Navarrete-Vázquez, G. (2006). Life Sci. 79, 430-435.  [CrossRef] [PubMed] [ChemPort]
Lehn, J.-M. (1990). Angew. Chem. Int. Ed. Engl. 29, 1304-1319.  [CrossRef]
Moreno-Diaz, H., Navarrete-Vázquez, G., Estrada-Soto, S. & Tlahuext, H. (2006). Acta Cryst. E62, o2601-o2602.  [CrossRef] [details]
Navarrete-Vázquez, G., Moreno-Diaz, H., Aguirre-Crespo, F., León-Rivera, I., Villalobos-Molina, R., Muñoz-Muñiz, O. & Estrada-Soto, S. (2006). Bioorg. Med. Chem. Lett. 16, 4169-4173.  [PubMed]
Saenger, W. (1984). Principles of Nucleic Acid Structure, pp. 132-140. New York: Springer-Verlag.
Sheldrick, G. M. (2003). SADABS. Version 2.10. Bruker AXS Inc., Madison, Wisconsin, USA.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.  [ISI] [CrossRef] [ChemPort] [details]
Wakelin, L. P. G. (1986). Med. Res. Rev. 6, 275-340.  [CrossRef] [ChemPort] [PubMed]


Acta Cryst (2008). E64, o608  [ doi:10.1107/S1600536808004510 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.